Related references
Note: Only part of the references are listed.Prognostic Significance of Serum PSA Level and Telomerase, VEGF and GLUT-1 Protein Expression for the Biochemical Recurrence in Prostate Cancer Patients after Radical Prostatectomy
Anna Gasinska et al.
PATHOLOGY & ONCOLOGY RESEARCH (2020)
Exploring the Condensation Reaction between Aromatic Nitriles and Amino Thiols To Optimize In Situ Nanoparticle Formation for the Imaging of Proteases and Glycosidases in Cells
Zixin Chen et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2020)
Trop2 is a driver of metastatic prostate cancer with neuroendocrine phenotype via PARP1
En-Chi Hsu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Radiofluorinated Smart Probes for Noninvasive PET Imaging of Legumain Activity in Living Subjects
Ling Qiu et al.
ANALYTICAL CHEMISTRY (2020)
Radiopharmacological evaluation of a caspase-3 responsive probe with optimized pharmacokinetics for PET imaging of tumor apoptosis
Shijie Wang et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2020)
Mouse Strains Influence Clearance and Efficacy of Antibody and Antibody-Drug Conjugate Via Fc-FcγR Interaction
Fu Li et al.
MOLECULAR CANCER THERAPEUTICS (2019)
Prostate-Specific Membrane Antigen (PSMA)-Targeted PET Imaging of Prostate Cancer: An Update on Important Pitfalls
Sara Sheikhbahaei et al.
SEMINARS IN NUCLEAR MEDICINE (2019)
Discovery and Structure-Based Optimization of Next-Generation Reversible Methionine Aminopeptidase-2 (MetAP-2) Inhibitors
Timo Heinrich et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Diagnosis of prostate cancer
Jean-Luc Descotes
ASIAN JOURNAL OF UROLOGY (2019)
The use of PET/CT in prostate cancer
Roger Li et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2018)
Boolean analysis identifies CD38 as a biomarker of aggressive localized prostate cancer
Debashis Sahoo et al.
Oncotarget (2018)
Prostate cancer-specific PET radiotracers: A review on the clinical utility in recurrent disease
Jaden D. Evans et al.
PRACTICAL RADIATION ONCOLOGY (2018)
PET Tracers Beyond FDG in Prostate Cancer
David M. Schuster et al.
SEMINARS IN NUCLEAR MEDICINE (2016)
Molecular Magnetic Resonance Imaging of Tumor Response to Therapy
Adam J. Shuhendler et al.
SCIENTIFIC REPORTS (2015)
Enzyme-Controlled Intracellular Self-Assembly of 18F Nanoparticles for Enhanced MicroPET Imaging of Tumor
Yaling Liu et al.
THERANOSTICS (2015)
Comparison of different prostatic markers in lymph node and distant metastases of prostate cancer
Angela Queisser et al.
MODERN PATHOLOGY (2015)
Androgen-deprivation therapy-induced aggressive prostate cancer with neuroendocrine differentiation
Julia Lipianskaya et al.
ASIAN JOURNAL OF ANDROLOGY (2014)
Differential suppression of the aryl hydrocarbon receptor nuclear translocator-dependent function by an aryl hydrocarbon receptor PAS-A-derived inhibitory molecule
Jinghang Xie et al.
BIOCHEMICAL PHARMACOLOGY (2014)
Bioorthogonal cyclization-mediated in situ self-assembly of small-molecule probes for imaging caspase activity in vivo
Deju Ye et al.
NATURE CHEMISTRY (2014)
Positron Emission Tomography Imaging of Drug-Induced Tumor Apoptosis with a Caspase-Triggered Nanoaggregation Probe
Bin Shen et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2013)
Managing Localized Prostate Cancer in the Era of Prostate-Specific Antigen Screening
James D. Brooks
CANCER (2013)
Activatable Oligomerizable Imaging Agents for Photoacoustic Imaging of Furin-Like Activity in Living Subjects
Anca Dragulescu-Andrasi et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2013)
Biosynthesis of Firefly Luciferin in Adult Lantern: Decarboxylation of L-Cysteine Is a Key Step for Benzothiazole Ring Formation in Firefly Luciferin Synthesis
Yuichi Oba et al.
PLOS ONE (2013)
p53 expression controls prostate cancer sensitivity to chemotherapy and the MDM2 inhibitor Nutlin-3
William H. Chappell et al.
CELL CYCLE (2012)
Purification and direct transformation of epithelial progenitor cells from primary human prostate
Andrew S. Goldstein et al.
NATURE PROTOCOLS (2011)
High Level PSMA Expression Is Associated With Early PSA Recurrence in Surgically Treated Prostate Cancer
Sarah Minner et al.
PROSTATE (2011)
Protein N-Terminal Processing: Substrate Specificity of Escherichia coli and Human Methionine Aminopeptidases
Qing Xiao et al.
BIOCHEMISTRY (2010)
An orally delivered small-molecule formulation with antiangiogenic and anticancer activity
Ofra Benny et al.
NATURE BIOTECHNOLOGY (2008)
Ectopic expression of methionine aminopeptidase-2 causes cell transformation and stimulates proliferation
L. A. Tucker et al.
ONCOGENE (2008)
Gene expression profiling identifies clinically relevant subtypes of prostate cancer
J Lapointe et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
The antiangiogenic agent TNP-470 requires p53 and p21CIP/WAF for endothelial cell growth arrest
JRJ Yeh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Cell cycle inhibition by the anti-angiogenic agent TNP-470 is mediated by p53 and p21WAF1/CIP1
Y Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
TNP-470: an angiogenesis inhibitor in clinical development for cancer
EA Kruger et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2000)
Two continuous spectrophotometric assays for methionine aminopeptidase
Y Zhou et al.
ANALYTICAL BIOCHEMISTRY (2000)
Share Paper
